Asahi Meguro Institute, Ltd.

About Us

About Us
Company Profile and History

Company Profile

Name

Asahi Meguro Institute, Ltd.

Head Office

541-0044

6-4, Fushimi-machi 2-chome, Chuo-ku, Osaka City (Yoshida Ikkan Building)

TEL:06-6223-1451

FAX:06-6223-1453

Kasai Factory

675-2101

318-1 Aza Kotaninoue-Otsu, Hanjo-cho, Kasai City, Hyogo

TEL:0790-49-2361

FAX:0790-49-1329

Founded

1925

Capital

35.2 million yen

Representative

President: Kenji Someya

Number of Employees

21 (as of Apr 2026)

Main Business

Manufacture, sale, and export of pharmaceutical ingredients for pharmaceuticals, health foods, animal feed, and other products.

History

The Meguro Institute, the predecessor of the Asahi Meguro Institute, was established in 1925 by the late Dr. Yōzaburo Meguro as the Osaka Experimental Therapy Institute.

After graduating from the Osaka Prefectural High School of Medicine in 1910, he studied biochemistry and later bacteriology and immunology under Dr. Kiyoshi Shiga at the Institute for Infectious Diseases. At the Kitasato Institute established by Dr. Shibasaburo Kitasato, he devoted 4 years of his life to researching with Professor Shiga. In 1922, he went to Europe and received training guidance from Dr. Holliday at the Pasteur Institute in Belgium and from Dr. Ramon at the Pasteur Institute in Paris. After returning to Japan in May 1925, the Osaka Experimental Therapy Institute was established in Kita Ward, Osaka City.

Chronology of the Meguro Institute

1925

Osaka Experimental Therapy Institute (Kita Ward, Osaka City) is established

1929

Lactobacillus preparation “Zeozenin” is released

1931

“Diphtheria hormo vaccine” is released

1937

The company is renamed as the “Meguro Institute”

“Diphtheria serum” is released

1945

Meguro Institute is destroyed due to a fire during the war

The company is immediately relocated to an immunization center that belongs to Koda Town, Ikeda City, Osaka.

1948

New laboratory is built in Masumi Town, Ikeda City, Osaka.

Reorganized as “Meguro Institute Co., Ltd.”

1950

Epidemic typhus vaccine is released

1952

Sale of Lactobacillus preparation “Zeozenin” is resumed

1958

Japanese encephalitis vaccine is released

1968

Lactic acid bacteria “Concbiogenin” is released

Bacillus subtilis “Bionattomin” is released

Both are supplied to pharmaceutical manufacturers as raw materials for gastrointestinal drugs

1977

Hepatitis B diagnostic kit “Rebirth Cell” is released

The company enters the clinical laboratory tests market

1980

Construction of new GMP-compliant Kansai Factory for pharmaceuticals in Kansai City, Hyogo Prefecture (current address) is completed

Production system for live bacterial preparations and organ-extracted preparations (currently discontinued) is expanded

1997

The company becomes a subsidiary of Maruishi Pharmaceutical Co., Ltd.

2003

Kasai Factory is expanded

2014

Construction of new facility at the Kasai Factory is completed

Ikeda Factory is closed and integrated into the Kasai Factory

The company relocates head office to Chuo Ward, Osaka City

2022

The company becomes a subsidiary of Teijin Limited

2025

The company becomes a subsidiary of Asahi Group Foods, Ltd. and is renamed Asahi Meguro Institute, Ltd.